Market Overview:
The global herpes simplex virus testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the market can be attributed to the increasing prevalence of herpes simplex virus, rising demand for rapid and accurate diagnosis, and technological advancements in diagnostic kits. The global herpes simplex virus testing market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into antibody/antigen based kit, viral culture test kits, and nucleic acid amplification-based kits. The antibody/antigen based kit segment is expected to dominate the global herpes simplex virus testing market during the forecast period owing to its high accuracy and rapid results. On the basis of application,the global herpes simplex virus testingmarketis divided into diagnostic centers hospitals,,and home use segments.
Product Definition:
Herpes simplex virus testing is a laboratory test that is used to determine if a person has been infected with the herpes simplex virus. The test can be used to diagnose both oral and genital herpes infections. The importance of herpes simplex virus testing depends on the individual's symptoms and whether or not they have been exposed to the virus.
Antibody/Antigen Based Kit:
Antibody/antigen based kits are used for the detection of antibodies and antigens in patients suffering from Herpes simplex virus (HSV). The antibody-based test is also known as an Enzyme-linked Immunosorbent Assay (ELISA) test. It is one of the most popular and reliable methods to diagnose diseases such as AIDS, Lyme disease, syphilis, pernicious anemia, etc.
Viral Culture Test Kits:
Viral culture test kits are used for the detection of Herpes Simplex Virus (HSV) in clinical samples. Viral culture is considered to be the gold standard method for testing of HSV infections. The method provides accurate results and has a high sensitivity owing to which it is being preferred over other methods such as serology tests.
Application Insights:
Based on the application, the global herpes simplex virus testing market is segmented into diagnostics centers, hospitals and home use. The diagnostics centers held the largest share in 2017 due to extensive usage of HSV-1 and -2 antibody/antigen based tests for clinical diagnosis. Moreover, an increasing number of laboratories is also contributing towards segment growth. For instance, according to data published by WHO in 2018, there are over 635 diagnostic laboratories operating across the globe with around 437 operational outside U.S., which provide direct patient services at site as well as remote locations without requiring a travel connection (Global Avertinment Services). This factor is anticipated to further boost demand for viral culture and nucleic acid amplification-based tests over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This is due to the presence of a large number of players, increasing prevalence of target diseases, and availability of advanced products for diagnosis. Moreover, these regions are witnessing an increase in awareness about testing and its benefits among people.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to rising incidence rates coupled with limited access to advanced diagnostic techniques and medicines in some countries such as India and China. These countries have one of the largest populations suffering from genital herpes simplex virus (HSV) infections worldwide but lack proper facilities for disease management leading to high unmet needs regarding diagnosis & treatment options globally.
Growth Factors:
- Increasing incidence of herpes simplex virus (HSV) infections across the globe.
- Growing awareness about HSV and its potential complications among people.
- Rising demand for accurate and rapid diagnosis of HSV infections.
- Technological advancements in herpes simplex virus testing procedures and products.
- Availability of government funding for research on herpes simplex virus testing
Scope Of The Report
Report Attributes
Report Details
Report Title
Herpes Simplex Virus Testing Market Research Report
By Type
Antibody/Antigen Based Kit, Viral Culture Test Kits, Nucleic Acid Amplification-based Kits
By Application
Diagnostic Centers, Hospitals, Home Use
By Companies
Abbott, ADI/American Diagnostica, Agilent Technologies, Chrono-Log, Corgenix, Decode Genetics, Diadexus, Diagnocure, Diagnostica Stago/Trinity Biotech, Diamedix, International Technidyne/Nexus DX, Kreatech/Leica, Polymedco, Qiagen, Roche, SDIX, Sequenom, Siemens
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Herpes Simplex Virus Testing Market Report Segments:
The global Herpes Simplex Virus Testing market is segmented on the basis of:
Types
Antibody/Antigen Based Kit, Viral Culture Test Kits, Nucleic Acid Amplification-based Kits
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Centers, Hospitals, Home Use
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- ADI/American Diagnostica
- Agilent Technologies
- Chrono-Log
- Corgenix
- Decode Genetics
- Diadexus
- Diagnocure
- Diagnostica Stago/Trinity Biotech
- Diamedix
- International Technidyne/Nexus DX
- Kreatech/Leica
- Polymedco
- Qiagen
- Roche
- SDIX
- Sequenom
- Siemens
Highlights of The Herpes Simplex Virus Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibody/Antigen Based Kit
- Viral Culture Test Kits
- Nucleic Acid Amplification-based Kits
- By Application:
- Diagnostic Centers
- Hospitals
- Home Use
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Herpes Simplex Virus Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Herpes simplex virus (HSV) testing is a blood test that can help diagnose herpes. HSV tests look for the presence of the HSV-1 or HSV-2 viruses. If you have herpes, your immune system will likely attack and destroy the virus even if you donu2019t have any symptoms. However, if you are infected with either type of herpes, having a positive HSV test may mean that you have already developed some signs and symptoms of the disease.
Some of the major companies in the herpes simplex virus testing market are Abbott, ADI/American Diagnostica, Agilent Technologies, Chrono-Log, Corgenix, Decode Genetics, Diadexus, Diagnocure, Diagnostica Stago/Trinity Biotech, Diamedix, International Technidyne/Nexus DX, Kreatech/Leica, Polymedco, Qiagen, Roche, SDIX, Sequenom, Siemens.
The herpes simplex virus testing market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Herpes Simplex Virus Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Herpes Simplex Virus Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Herpes Simplex Virus Testing Market - Supply Chain
4.5. Global Herpes Simplex Virus Testing Market Forecast
4.5.1. Herpes Simplex Virus Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Herpes Simplex Virus Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Herpes Simplex Virus Testing Market Absolute $ Opportunity
5. Global Herpes Simplex Virus Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Herpes Simplex Virus Testing Market Size and Volume Forecast by Type
5.3.1. Antibody/Antigen Based Kit
5.3.2. Viral Culture Test Kits
5.3.3. Nucleic Acid Amplification-based Kits
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Herpes Simplex Virus Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Herpes Simplex Virus Testing Market Size and Volume Forecast by Application
6.3.1. Diagnostic Centers
6.3.2. Hospitals
6.3.3. Home Use
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Herpes Simplex Virus Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Herpes Simplex Virus Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Herpes Simplex Virus Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Herpes Simplex Virus Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Herpes Simplex Virus Testing Demand Share Forecast, 2019-2026
9. North America Herpes Simplex Virus Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Herpes Simplex Virus Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Herpes Simplex Virus Testing Market Size and Volume Forecast by Application
9.4.1. Diagnostic Centers
9.4.2. Hospitals
9.4.3. Home Use
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Herpes Simplex Virus Testing Market Size and Volume Forecast by Type
9.7.1. Antibody/Antigen Based Kit
9.7.2. Viral Culture Test Kits
9.7.3. Nucleic Acid Amplification-based Kits
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Herpes Simplex Virus Testing Demand Share Forecast, 2019-2026
10. Latin America Herpes Simplex Virus Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Herpes Simplex Virus Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Herpes Simplex Virus Testing Market Size and Volume Forecast by Application
10.4.1. Diagnostic Centers
10.4.2. Hospitals
10.4.3. Home Use
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Herpes Simplex Virus Testing Market Size and Volume Forecast by Type
10.7.1. Antibody/Antigen Based Kit
10.7.2. Viral Culture Test Kits
10.7.3. Nucleic Acid Amplification-based Kits
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Herpes Simplex Virus Testing Demand Share Forecast, 2019-2026
11. Europe Herpes Simplex Virus Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Herpes Simplex Virus Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Herpes Simplex Virus Testing Market Size and Volume Forecast by Application
11.4.1. Diagnostic Centers
11.4.2. Hospitals
11.4.3. Home Use
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Herpes Simplex Virus Testing Market Size and Volume Forecast by Type
11.7.1. Antibody/Antigen Based Kit
11.7.2. Viral Culture Test Kits
11.7.3. Nucleic Acid Amplification-based Kits
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Herpes Simplex Virus Testing Demand Share, 2019-2026
12. Asia Pacific Herpes Simplex Virus Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Herpes Simplex Virus Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Herpes Simplex Virus Testing Market Size and Volume Forecast by Application
12.4.1. Diagnostic Centers
12.4.2. Hospitals
12.4.3. Home Use
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Herpes Simplex Virus Testing Market Size and Volume Forecast by Type
12.7.1. Antibody/Antigen Based Kit
12.7.2. Viral Culture Test Kits
12.7.3. Nucleic Acid Amplification-based Kits
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Herpes Simplex Virus Testing Demand Share, 2019-2026
13. Middle East & Africa Herpes Simplex Virus Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Herpes Simplex Virus Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Herpes Simplex Virus Testing Market Size and Volume Forecast by Application
13.4.1. Diagnostic Centers
13.4.2. Hospitals
13.4.3. Home Use
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Herpes Simplex Virus Testing Market Size and Volume Forecast by Type
13.7.1. Antibody/Antigen Based Kit
13.7.2. Viral Culture Test Kits
13.7.3. Nucleic Acid Amplification-based Kits
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Herpes Simplex Virus Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Herpes Simplex Virus Testing Market: Market Share Analysis
14.2. Herpes Simplex Virus Testing Distributors and Customers
14.3. Herpes Simplex Virus Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. ADI/American Diagnostica
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Agilent Technologies
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Chrono-Log
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Corgenix
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Decode Genetics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Diadexus
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Diagnocure
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Diagnostica Stago/Trinity Biotech
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Diamedix
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. International Technidyne/Nexus DX
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Kreatech/Leica
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Polymedco
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Qiagen
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Roche
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. SDIX
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Sequenom
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Siemens
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
